Adam Schaffner
Plastic Surgery · New York, NYNPI 1629182548
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $64,062 of the $71,424 with a category attached, or 89.7%. Lumenis BE LTD accounts for 89.4% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2023 at $62,572 and has fallen 96.4% since, to $2,245 in 2025. Among plastic surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 34 payments — averaging $2100.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lumenis BE LTD$64K
- AbbVie$4K
- BD$934
- KCI USA, Inc.$850
- Sientra, Inc.$695
- Musculoskeletal Transplant Foundation Inc.$314
- plus $1K from 8 others
Across 2 payments — averaging $192,161 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Davol Inc.$384K
What the payments were for
- Consulting fees$1,7842%
- Speaking & faculty fees$64,06290%
- Food & beverage$2,0873%
- Education$870%
- Gifts$3,4045%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lumenis BE LTD | 2 | $63,889 |
| AbbVie(2 entities) | 6 | $3,724 |
| BD | 1 | $934 |
| KCI USA, Inc. | 1 | $850 |
| Sientra, Inc. | 8 | $695 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $314 |
| Galderma Laboratories, L.p. | 3 | $229 |
| Revance Therapeutics, Inc. | 4 | $207 |
| Merz North America, Inc. | 1 | $172 |
| Vertex | 1 | $131 |
| UCB, Inc. | 1 | $129 |
| Sanara Medtech Inc. | 2 | $89 |
| Integra Lifesciences Corporation | 2 | $49 |
| TEI Biosciences Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$71,424 in reported general payments places this provider in the 95th percentile of 363 plastic surgery providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 11 | $94 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in New York
- Sachin ShridharaniNew York$1.1M
- Scot GlasbergNew York$959K
- Nolan KarpNew York$900K
- Sydney ColemanNew York$729K
- David RapaportNew York$578K
- Richard SwiftNew York$487K
- Michael KaneNew York$250K
- Z LorencNew York$225K
- Joseph DayanNew York$123K
- Anna AvalianiNew York$93K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.